Results 51 to 60 of about 13,599 (199)
Locus for quantitative HDL-cholesterol on chromosome 10q in Finnish families with dyslipidemia
Decreased HDL-cholesterol (HDL-C) and familial combined hyperlipidemia (FCHL) are the two most common familial dyslipidemias predisposing to premature coronary heart disease (CHD).
Heidi E. Lilja +10 more
doaj +1 more source
The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus (SARS-CoV)-2 has resulted in the death of more than 328,000 persons worldwide in the first 5 months of 2020.
Stephen L. Sturley +6 more
doaj +1 more source
Lipoprotein(a) in familial hypercholesterolemia: Tips from family history
Beatrice Dal Pino +4 more
doaj +1 more source
Michel FarnierPoint Médical, Dijon, FranceAbstract: Mixed dyslipidemia is a common lipid disorder characterized by the presence of an atherogenic lipoprotein phenotype due to abnormalities in various atherogenic and antiatherogenic lipoproteins ...
Michel Farnier
core
FREQUENCY OF CO-MORBIDITIES ASSOCIATED WITH SPINAL CORD INJURY
Objective: To determine the frequencies of comorbidities (dyslipidemias, diabetes mellitus, and hypertension) in patients with spinal cord injury (SCI) of duration > 1 year. Study Design: Case control.
Aisha Ayyub +4 more
doaj +2 more sources
Lipoprotein(a) apheresis restores coronary microcirculation in refractory angina
Francesco Sbrana +5 more
doaj +1 more source
Difference in prostate cancer incidence around sixty years: effects of age and metabolic diseases
We examined the risk of prostate cancer in the Korean population stratified on the basis of age group and risk based on metabolic diseases, using National Health Insurance System (NHIS) data.
Jin Bong Choi +4 more
doaj +1 more source
Managing dyslipidemia in chronic kidney disease: a comprehensive overview of evidence and recommendations [PDF]
Patients with chronic kidney disease (CKD) have a significantly increased risk of developing cardiovascular disease (CVD), making dyslipidemia management a critical component of cardiovascular risk reduction in this population.
Ji Yoon Kim, Suk Min Chung, Nam Hoon Kim
doaj +1 more source
Although genetic factors strongly influence lipid metabolism, genetic dyslipidemias refer to specific monogenic defects that significantly alter the function of proteins involved in lipid metabolism. Familial hypercholesterolemia results from mutations in the genes coding for LDL-receptor, apolipoprotein B100 (apoB100), PCSK9, or LDLRAP1.
openaire +2 more sources

